In a patient with cisplatin-resistant ovarian cancer, CA 125 (a tumor marker) levels were decreased from 295 to 55 units/mL after two courses of quercetin (420 mg/m 2 ), whereas in another patient with hepatocellular carcinoma, serum alpha-fetoprotein levels decreased after several courses of treatment
The test ($99 add-on) maps genetic variants in GLP1R, GIPR, FTO, and MC4R pathways, revealing how your body processes GLP-1 compounds
This helps assess the peptides effects and reduce risks
GLP-1 1.02% (95% confidence interval [CI], 1.10~-0.94), 0.13% (95% CI, 0.21~-0.04) [5]
Attaining a blood Ca/Mg around 2.0 can also be challenging
[7] It is advisable for patients to inform their healthcare provider of all medications and supplements they are taking, so that potential interactions can be monitored and managed appropriately